
South African President Cyril Ramaphosa launched a nearly $200 billion investment drive aimed at accelerating economic recovery and industrialization in the face of growing worry over the impact of the Iran war on the continent’s biggest economy.
For more than a decade, South Africa’s economy has barely grown, leaving it with crumbling infrastructure and the need to create jobs in a country where one in three people are unemployed. Ramaphosa’s pitch to investors in Johannesburg this week was that South Africa has fixed the worst bottlenecks: He said the country is opening key sectors to private capital and is ready for large scale investments.
Ramaphosa said the effort will run through 2030 with delegates at the South African Investment Conference pledging $53 billion across 31 projects spanning energy, logistics, manufacturing, and digital infrastructure. They include Coca-Cola’s $1 billion expansion plan, and a $3.6 billion commitment from Sasol — the world’s biggest maker of fuel from coal — to upgrade operations.
latest_posts
- 1
Manual for Financial plan Agreeable PC - 2
Five EU states press for windfall taxes on fossil energy sector - 3
Slovakia rejects EU call to scrap higher fuel prices for foreign cars - 4
Hubble Space Telescope spies dusty debris from two cosmic collisions - 5
Sanofi to acquire hepatitis B vaccine maker Dynavax for $2.2 billion
6 Eyewear Brands Worth Purchasing
Living in the dark: Gaza’s struggle for electricity
Black Friday streaming deals 2025: Grab the Disney+ Hulu bundle for only $5 and save over 60%
Factbox-Weight-loss drug developers line up to tap lucrative market as competition heats up
3 astronauts settle into their new life in orbit | On the International Space Station this week Dec. 1-5, 2025
Former defense minister Gallant vacated home over security threat under Shin Bet direction
Mystery foot suggests a second early human relative lived alongside Lucy
Putin critic gets six years in penal colony, vows hunger strike
Impact of NIH funding reductions felt in cancer and infectious disease trials













